SEC Form 4 · accession 0000899243-18-020506
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Sprague
Officer — Chief Financial Officer
Period of report
Jul 20, 2018
Accepted (ET)
Jul 24, 2018 · 2:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2018 | F | 5,619 | $6.72 | D | 11,673 | D |
Table II — derivative securities
No Table II lines on this filing.